Close Menu

Tecan

Enigma Diagnostics and GlaxoSmithKline said today that they have signed a supply and commercialization agreement for molecular diagnostic tests for use on Engima's fully automated, sample-to-answer real-time PCR system, breathing new life into a partnership begun in 2009.

According to the company, the new product is an example of its direction for next-gen sequencing sample prep: flexible and automated.

The platform can prepare almost 1,000 samples in less than 24 hours using the SISCAPA workflow, Tecan said.

Agilent Technologies, DxNA, Toyo Seikan Kaisha, Gen-Probe, NuGen, and 3M are awarded US patents.

IP Roundup: May 10, 2011

Premium

Advanced Liquid Logic, Duke University, NuGen Technologies, Stanford University, Schott, Corning, Immucor

However, the company confirmed that it is no longer commercializing its test, the Enigma ML Influenza A/B detection assay, in partnership with GlaxoSmithKline as was previously reported.

Under the terms of the agreement, NuGen's Ovation RNA-seq kit will be the first to be automated on the Apollo 324 system and will be available commercially this year.

New Products: Apr 12, 2011

Premium

NuGen's Ovation RNA-seq for Roche's GS systems, NEB and Sequenom's EpiMark Methylated DNA Enrichment Kit, Complete Genomics releases 29 whole-genome datasets

The companies will co-promote NuGen's Ovation RNA-Seq system with 454 Life Sciences' GS FLX and GS Junior systems to enable whole-transcriptome profiling of low-abundance samples.

The firms will automate NuGen's NGS Sample Preparation workflows on IntegenX's Apollo series next-generation sequencing library preparation instruments.

Pages

Public health experts call for a transparent COVID-19 vaccine approval process in a letter; the Food and Drug Administration commissioner assures science-based approval.

The Verge reports that new gene-naming guidelines aim in part to avoid Excel-related name change confusion.

In Nature this week: tuatara genome sequence aids in understanding amniote evolution, and more.

According to the Guardian, UK virologists say in a letter to officials that their expertise has been pushed aside in COVID-19 response plans.